Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunnelling wounds.

Cook Medical, founded in 1963, creates innovative medical devices to empower healthcare professionals, helping patients live fully. As healthcare evolves, demand grows for groundbreaking products and better business practices. In an exciting new phase, Cook enhances its unique product portfolio and customer experiences. As a privately held company, Cook embraces the future, guided by values and commitment to clinicians and patients. We expand impact through four pillars: Invention, Connection, People, and Community. Our Vascular and MedSurg divisions collaborate with professionals to address unmet needs, driving innovation to improve lives with a relentless focus on getting patients back to living.

180 Health Services is a leading distributor of advanced regenerative products and services, supplying life-enhancing solutions to providers nationwide. Specializing in skin graft biologics for non-healing wound recovery, we bring 100+ years of combined healthcare leadership experience to the industry.

More than just a supplier—we act as a true business partner, and assist with streamlining every process to make your life easier so you can focus on what truly matters: providing outstanding patient care. Our expert account management team is dedicated to delivering exceptional service, while our commitment to the clinical success of providers and patients is our top priority. At 180 Health Services, your needs are at the heart of everything we do.

LIVE YOUR BEST LIFE, NOW AND IN THE FUTURE

We understand that the first step to living your best life is good health. Everything we make is designed to help you do just that. That’s our commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health.

The Auryon laser is approved for atherectomy in infrainguinal arteries, in-stent restenosis, and for aspiration of thrombus adjacent to stenosis as a secondary peripheral indication.  Our technology is well-published and studied for it’s safety and effectiveness in peripheral arteries due to it’s unique ability to only target disease while not harming healthy arterial layers.  The Auryon laser has 3 methods of action:  1. Debulking mixed-morphology disease, 2. Aspirating disease and thrombus adjacent to stenoses, and 3. Cracking medial arterial calcium below the knee.  We have also recently released radial length laser catheters to round out PAD practices’ ability to treat all comers needing critical PAD therapy.

Engineered Tissue Solutions (ETS) is an innovative company in the medical device industry, dedicated to empowering wound healing with bioactive glass solutions. Our flagship product, Mirragen®, represents a breakthrough as the first FDA-cleared bioactive glass-based technology in wound care. Mirragen® is a borate-based bioactive glass fiber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.

Essity is a global, leading hygiene and health company. Every day, our products, solutions, and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society.

We provide high-quality wound and incontinence care, orthopedic, and compression products. Our innovative and cost-effective solutions, coupled with our expertise, cutting edge technology, and global coverage, allow for better patient care outcomes.

Essity sells in approximately 150 countries under leading global brands Cutimed®, Hydrofera Blue®, Leukoplast®, JOBST®, Delta-Cast®, TENA®, and more.

Learn more at www.essity.com.

GR Consulting, LLC is a small boutique consulting and advisory fi rm that specializes in the wound care and surgical wound care markets. GR focuses on start-up and early stage companies who need additional bandwidth to support their expanding business.
We are a small team of senior leaders who provide support in strategy, geographic expansion, market access/reimbursement, health economics and outcomes research, regulatory, clinical trial design/execution, and strategic partner searches. Our team has more than 125 years of combined senior level experience and provides the leadership firepower, technical ingenuity, a strong industry network and the expertise to help execute the correct business strategy at the right time. Finally, our business model is setup to deliver a customized approach to each client’s specific business needs without the bloated overhead and generalist approach that most mid-sized or large consulting firms provide.

Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports realtime decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable the
body to regenerate tissues. Developed and manufactured in Isafjordur, Iceland, Kerecis medical products are authorized for sale in Europe, the United States, and several other jurisdictions for human-tissue repair. Thousands of patients are treated annually with our technology. And we are broadening our product line to address many more types of soft tissue damage.

As a global leader in regenerative medicine, LifeNet Health continues to push the boundaries to give healing every advantage. The organization offers groundbreaking solutions that support healthcare providers and power the work of scientific researchers. This forward-focused approach has improved life for millions of patients, all while honoring donor heroes and their families.

At Medaxis we are defining the future of wound therapy. Leveraging our 60+ years of expertise in medical vacuum technology, our systems prepare the wound bed for healing and create an optimal wound healing environment. We are eliminating burdensome processes, simplifying the continuity of care and ushering in a new paradigm in wound therapy.

Mölnlycke is a world-leading MedTech company, with a purpose to revolutionize care for people and planet.

Net Health is a trusted partner for over 25,000 healthcare organizations spanning the continuum of care. Thirty years of experience in wound care, rehab therapy, post-acute, and occupational health have informed specialized technology solutions that help providers, payers and employers leverage predictive analytics and patient engagement tools to harness data for human health. With our software clients manage workflow efficiently, engage effectively with patients, measure  performance, and improve outcomes to drive growth.

Advancing Healing and Recovery Beyond Expectations

From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need.

Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure — regardless of wound type.

Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum, from developing and operating wound centers in partnership with hospitals, through delivering professional wound care in nursing facilities and in-home settings, to supporting patients through the coordination of wound supplies.

At Solventum, we create breakthrough solutions for our customers’ toughest challenges by pioneering game-changing innovations at the intersection of health, material and data science to change patients’ lives for the better — while enabling healthcare professionals to perform at their best.

At Tiger Wound Care, we are committed to advancing wound care through innovative, science-driven tissue technologies. Our focus is on cell and tissue technologies that support the repair, reconstruction, replacement, or supplementation of the patient’s own tissue.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has more than 70,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com

Clara Care is a specialized durable medical equipment supplier focused in the complex, chronic condition and wound care space. Clara dispenses products and supports patients in wound care, ostomy, NPWT, lymphedema, diabetes, and incontinence. We believe that each patient deserves dedicated nurse specialist support to ensure personalized care and education at every step.

Beyond Supplies: Advancing Care Through Connection, Support, and Expertise.

www.clarahealthcare.com

Integra LifeSciences (Integra) was founded in 1989 based on a vision to expand access to promising technology that enables the body to regenerate damaged or diseased tissue. Grounded on this vision, the company revolutionized the field of regenerative medicine and has since grown to be a leading global medical technology company innovating new treatment pathways in surgical, neurologic and regenerative care to advance patient outcomes and set new standards of care.
Integra now has a broad portfolio of innovative products and solutions used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus, hemorrhagic stroke, and other neurological and ear, nose and throat conditions. Our regenerative tissue technologies include products that address soft tissue, peripheral nerve and tendon repairs and are used for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery.

MIMEDX is a pioneer and leader in placental biologics focused on delivering innovative solutions to patients and the healthcare professionals who treat them. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX has been dedicated to providing a leading portfolio of products for applications in the wound care, burn, and Surgical Recovery sectors of healthcare. While our focus is on advancing clinical and scientific evidence to further substantiate the vast therapeutic potential of placental tissue, we’re ultimately here to transform the lives of patients. We do that by offering breakthrough innovations in advanced wound care and surgical applications.

Shockwave Medical is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind IVL technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes.